Clinical Trial Update: Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Surufatinib alone or in combination with Vinorelbine for advanced Non-Small Cell Lung Cancer; current trial status is unknown per Clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Surufatinib (Surufatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN